These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23387216)

  • 1. [Effect of single doses of HX0507 on QTc intervals in healthy people: a phase I safety and tolerability study].
    Yi XQ; Li R; Zhang WS; Liu J; Xu J; Liao TZ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):868-72. PubMed ID: 23387216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials.
    Yang H; Laurenza A; Williams B; Patten A; Hussein Z; Ferry J
    Epilepsy Res; 2015 Aug; 114():122-30. PubMed ID: 26088895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in QTc associated with a rapid bolus dose of dexmedetomidine in patients receiving TIVA: a retrospective study.
    Görges M; Whyte SD; Sanatani S; Dawes J; Montgomery CJ; Ansermino JM
    Paediatr Anaesth; 2015 Dec; 25(12):1287-93. PubMed ID: 26507917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effects of bitopertin (RG1678) on cardiac repolarization: a thorough corrected QT study in healthy male volunteers.
    Hofmann C; Banken L; Hahn M; Swearingen D; Nagel S; Martin-Facklam M
    Clin Ther; 2012 Oct; 34(10):2061-71. PubMed ID: 22980315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thorough QT study of the effects of vildagliptin, a dipeptidyl peptidase IV inhibitor, on cardiac repolarization and conduction in healthy volunteers.
    He YL; Zhang Y; Serra D; Wang Y; Ligueros-Saylan M; Dole WP
    Curr Med Res Opin; 2011 Jul; 27(7):1453-63. PubMed ID: 21609207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olaparib does not cause clinically relevant QT/QTc interval prolongation in patients with advanced solid tumours: results from two phase I studies.
    Swaisland H; Plummer R; So K; Garnett S; Bannister W; Fabre MA; Dota C; Fielding A
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):775-84. PubMed ID: 27553432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. For neonatal ECG screening there is no reason to relinquish old Bazett's correction.
    Stramba-Badiale M; Karnad DR; Goulene KM; Panicker GK; Dagradi F; Spazzolini C; Kothari S; Lokhandwala YY; Schwartz PJ
    Eur Heart J; 2018 Aug; 39(31):2888-2895. PubMed ID: 29860404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the potential for QTc prolongation in patients with solid tumors receiving nivolumab.
    Agrawal S; Waxman I; Lambert A; Roy A; Darbenzio R
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):635-41. PubMed ID: 26861469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cut-offs for screening prolonged QT intervals from Fridericia's formula in children and adolescents.
    Hazeki D; Yoshinaga M; Takahashi H; Tanaka Y; Haraguchi Y; Abe M; Koga M; Fukushige T; Nagashima M
    Circ J; 2010 Aug; 74(8):1663-9. PubMed ID: 20534944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis of electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteers.
    Wang Z; Grasela DM; Krishna G
    Clin Ther; 2007 Jun; 29(6):1098-106. PubMed ID: 17692724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intravenous ondansetron on QTc interval in children with gastroenteritis.
    Hoffman RJ; Alansari K
    Am J Emerg Med; 2018 May; 36(5):754-757. PubMed ID: 29029798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of different general anaesthetics on ventricular repolarisation in robot-assisted laparoscopic prostatectomy.
    Park JH; Lee KY; Choi YD; Lee J; Shin HJ; Han DW; Baek J; Kim SY
    Acta Anaesthesiol Scand; 2020 Oct; 64(9):1243-1252. PubMed ID: 32531070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized Trial to Assess the Effect of Doravirine on the QTc Interval Using a Single Supratherapeutic Dose in Healthy Adult Volunteers.
    Khalilieh SG; Yee KL; Fan L; Liu R; Heber W; Dunzo E; Triantafyllou I; Hussaini A; Iwamoto M
    Clin Drug Investig; 2017 Oct; 37(10):975-984. PubMed ID: 28785879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of heart rate correction methods for the QT interval.
    Desai M; Li L; Desta Z; Malik M; Flockhart D
    Br J Clin Pharmacol; 2003 Jun; 55(6):511-7. PubMed ID: 12814443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of elotuzumab on QT interval and cardiac safety in patients with multiple myeloma.
    Passey C; Darbenzio R; Jou YM; Lynch M; Gupta M
    Cancer Chemother Pharmacol; 2016 Dec; 78(6):1237-1244. PubMed ID: 27796540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of desflurane at less than 1 MAC on QT interval prolongation induced by tracheal intubation.
    Kim SH; Park SY; Chae WS; Jin HC; Lee JS; Kim YI
    Br J Anaesth; 2010 Feb; 104(2):150-7. PubMed ID: 20008860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure-QT analysis for sonidegib (LDE225), an oral inhibitor of the hedgehog signaling pathway, for measures of the QT prolongation potential in healthy subjects and in patients with advanced solid tumors.
    Quinlan M; Zhou J; Hurh E; Sellami D
    Eur J Clin Pharmacol; 2016 Dec; 72(12):1427-1432. PubMed ID: 27663457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effect of the EGFR antibody-drug conjugate ABT-414 on QT interval prolongation in patients with advanced solid tumors likely to over-express EGFR.
    Munasinghe WP; Mittapalli RK; Li H; Hoffman DM; Holen KD; Menon RM; Xiong H
    Cancer Chemother Pharmacol; 2017 May; 79(5):915-922. PubMed ID: 28349167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study.
    Hulhoven R; Rosillon D; Letiexhe M; Meeus MA; Daoust A; Stockis A
    Eur J Clin Pharmacol; 2007 Nov; 63(11):1011-7. PubMed ID: 17891537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of inotuzumab ozogamicin on the QT interval in patients with haematologic malignancies using QTc-concentration modelling.
    Hibma JE; Kantarjian HM; DeAngelo DJ; Boni JP
    Br J Clin Pharmacol; 2019 Mar; 85(3):590-600. PubMed ID: 30536405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.